438 related articles for article (PubMed ID: 32526750)
1. Nonchemotherapy Treatment of Immunoglobulin Light Chain Amyloidosis.
Van Doren L; Lentzsch S
Acta Haematol; 2020; 143(4):373-380. PubMed ID: 32526750
[TBL] [Abstract][Full Text] [Related]
2. Fibril-directed Therapies in Systemic Light Chain AL Amyloidosis.
Bhutani D; Leng S; Lentzsch S
Clin Lymphoma Myeloma Leuk; 2019 Sep; 19(9):555-559. PubMed ID: 31262668
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies in the treatment of AL amyloidosis: co-targetting the plasma cell clone and amyloid deposits.
Popkova T; Hajek R; Jelinek T
Br J Haematol; 2020 Apr; 189(2):228-238. PubMed ID: 32072615
[TBL] [Abstract][Full Text] [Related]
4. Management of AL amyloidosis in 2020.
Palladini G; Milani P; Merlini G
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):363-371. PubMed ID: 33275753
[TBL] [Abstract][Full Text] [Related]
5. Daratumumab, pomalidomide, and dexamethasone as a bridging therapy to autologous stem cell transplantation in a case of systemic light-chain amyloidosis with advanced cardiac involvement.
Arnall JR; Usmani SZ; Adamu H; Mishkin J; Bhutani M
J Oncol Pharm Pract; 2019 Jun; 25(4):1021-1025. PubMed ID: 30477388
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in the Diagnosis, Risk Stratification, and Management of Systemic Light-Chain Amyloidosis.
Vaxman I; Gertz M
Acta Haematol; 2019; 141(2):93-106. PubMed ID: 30650422
[TBL] [Abstract][Full Text] [Related]
7. Management of AL amyloidosis in 2020.
Palladini G; Milani P; Merlini G
Blood; 2020 Dec; 136(23):2620-2627. PubMed ID: 33270858
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2018 Sep; 93(9):1169-1180. PubMed ID: 30040145
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin light chain amyloidosis: 2022 update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2022 Jun; 97(6):818-829. PubMed ID: 35429180
[TBL] [Abstract][Full Text] [Related]
10. Daratumumab: A Review in Newly Diagnosed Systemic Light Chain Amyloidosis.
Blair HA
Drugs; 2022 Apr; 82(6):683-690. PubMed ID: 35416593
[TBL] [Abstract][Full Text] [Related]
11. Emerging drugs for the treatment of light chain amyloidosis.
Chakraborty R; Lentzsch S
Expert Opin Emerg Drugs; 2020 Sep; 25(3):299-317. PubMed ID: 32731778
[TBL] [Abstract][Full Text] [Related]
12. Advancements and future trends of immunotherapy in light-chain amyloidosis.
Mahadevia H; Ponvilawan B; Sharma P; Al-Obaidi A; Qasim H; Koyi J; Anwer F; Raza S
Crit Rev Oncol Hematol; 2023 Mar; 183():103917. PubMed ID: 36696931
[TBL] [Abstract][Full Text] [Related]
13. Conventional Therapy for Amyloid Light-Chain Amyloidosis.
Milani P; Palladini G
Acta Haematol; 2020; 143(4):365-372. PubMed ID: 32353854
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2024 Feb; 99(2):309-324. PubMed ID: 38095141
[TBL] [Abstract][Full Text] [Related]
15. Novel challenges in the management of immunoglobulin light chain amyloidosis: from the bench to the bedside.
Basset M; Nuvolone M; Palladini G; Merlini G
Expert Rev Hematol; 2020 Sep; 13(9):1003-1015. PubMed ID: 32721177
[TBL] [Abstract][Full Text] [Related]
16. Supportive Care in AL Amyloidosis.
Cibeira MT; Ortiz-Pérez JT; Quintana LF; Fernádez de Larrea C; Tovar N; Bladé J
Acta Haematol; 2020; 143(4):335-342. PubMed ID: 32235118
[TBL] [Abstract][Full Text] [Related]
17. High-Dose Melphalan and Autologous Peripheral Blood Stem Cell Transplantation in AL Amyloidosis.
Sanchorawala V
Acta Haematol; 2020; 143(4):381-387. PubMed ID: 32248194
[TBL] [Abstract][Full Text] [Related]
18. [Treatment strategy for immunoglobulin light chain amyloidosis].
Fuchida SI
Rinsho Ketsueki; 2021; 62(8):1160-1166. PubMed ID: 34497203
[TBL] [Abstract][Full Text] [Related]
19. Use of novel therapies in the treatment of light chain amyloidosis.
Varga C; Titus SE; Toskic D; Comenzo RL
Blood Rev; 2019 Sep; 37():100581. PubMed ID: 31167719
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy in AL Amyloidosis.
Zhang Y; Comenzo RL
Curr Treat Options Oncol; 2022 Jul; 23(7):1059-1071. PubMed ID: 35635625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
